Culturally Centered CBT for Latinx Youth
A Culturally Centered CBT Protocol for Suicidal Ideation and Suicide Attempts Among Latinx Youth
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Yovanska Duarte-Velez, PhD
- Phone Number: 401-432-1651
- Email: yovanska.duart-velez@lifespan.org
Study Contact Backup
- Name: Gisela Jimenez-Colon, PhD
- Phone Number: 401-432-1059
- Email: gjimenezcolon@lifespan.org
Study Locations
-
-
Rhode Island
-
Providence, Rhode Island, United States, 02903
- Hasbro Children's Hospital (Inpatient Psychiatric Unit)
-
Riverside, Rhode Island, United States, 02915
- Bradley Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Latinx, defined as have been born in a Latin country or having at least one biological parent, grandparent or an ancestor that was born in a Latin country
- Severe Suicidal Ideation (SI), defined as a score of 22 or above on the SIQ-JR or having made a Suicide Attempts (SA) within the last 3 months
- Caregivers and adolescents fluent in Spanish or English language and legal guardian willing to participate
Exclusion Criteria:
- psychosis
- substance use disorder, rated severe on the DSM-5
- cognitive impairment represented by an IQ below 85
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: SCBT-SB
A culturally centered CBT treatment protocol called Socio-Cognitive Behavioral Therapy for Suicidal Behavior (SCBT-SB)
|
The SCBT-SB is a manualized and flexible intervention that uses a modular approach to the treatment of adolescent suicidality.
After the first mandatory module (Crisis module), and at the end of each subsequent module, the therapist works with the teen and caregivers to determine the next one.
The Crisis Module is fixed and represent the intervention core skills with 9 sessions.
The optional coping skills modules include Thoughts, Emotional Regulation, Family Communication, Social Interaction, Activity, Trauma, and Substance Use.
|
|
Active Comparator: Treatment as Usual
Treatment as usual is base on the standard care for teens and their parents under a community mental health center.
|
Therapy that typically consist of eclectic individual therapy including CBT, emphasizing psychoeducation and providing support, with occasional conjoint parent sessions or individual caregiver sessions.
The treatment as usual primarily focuses on generating solutions to the adolescent and caregivers most urgent concerns.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Suicidal ideation
Time Frame: Change from baseline to 3 month, 6 month, and 12 month follow up points.
|
Suicidal ideation measured using the Suicide Ideation Questionnaire-Junior (SIQ-JR), the minimum score is 0 and the maximum 90.
A higher score represents increase severity and frequency of suicidal thoughts.
|
Change from baseline to 3 month, 6 month, and 12 month follow up points.
|
|
Depressive symptoms by self-report
Time Frame: Change from baseline to 3 month, 6 month, and 12 month follow up points.
|
Level of depressive symptomatology using the Children Depression Inventory 2 (CDI-2), the minimum score is 0 and the maximum 56.
A higher score means higher level of depressive symptoms.
|
Change from baseline to 3 month, 6 month, and 12 month follow up points.
|
|
Depressive symptoms by clinical interview
Time Frame: Change from baseline to 3 month, 6 month, and 12 month follow up points.
|
Depressive symptoms using the Children's Depression Rating Scale-Revised (CDRS-R), the minimum raw score is 17 and the maximum 113.
A higher score means higher level of depressive symptoms.
|
Change from baseline to 3 month, 6 month, and 12 month follow up points.
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Suicide Attempts
Time Frame: Change from baseline to 6 months follow-up
|
Number of total actual and interrupted suicide attempts using the Columbia-Suicide Severity Rating Scale (C-SSRS)
|
Change from baseline to 6 months follow-up
|
|
Suicide Attempts
Time Frame: Change from 6 months to 12 months follow-up
|
Actual and interrupted suicide attempts (yes or no) using the Columbia-Suicide Severity Rating Scale (C-SSRS)
|
Change from 6 months to 12 months follow-up
|
|
Suicide Attempts
Time Frame: Change from baseline to 12 months follow-up
|
Actual and interrupted suicide attempts (yes or no) using the Columbia-Suicide Severity Rating Scale (C-SSRS)
|
Change from baseline to 12 months follow-up
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Yovanska Duarte-Velez, PhD, Bradley Hospital
Publications and helpful links
General Publications
- Duarte-Velez Y, Torres-Davila P, Spirito A, Polanco N, Bernal G. Development of a treatment protocol for Puerto Rican adolescents with suicidal behaviors. Psychotherapy (Chic). 2016 Mar;53(1):45-56. doi: 10.1037/pst0000044.
- Duarte-Velez Y, Jimenez-Colon G, Jones RN, Spirito A. Socio-Cognitive Behavioral Therapy for Latinx Adolescent with Suicidal Behaviors: A Pilot Randomized Trial. Child Psychiatry Hum Dev. 2024 Jun;55(3):754-767. doi: 10.1007/s10578-022-01439-z. Epub 2022 Oct 1.
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 1437564-1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.